Global Ophthalmic Biologics Supply, Demand and Key Producers, 2024-2030
The global Ophthalmic Biologics market size is expected to reach $ million by 2030, rising at a market growth of % CAGR during the forecast period (2024-2030).
This report studies the global Ophthalmic Biologics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ophthalmic Biologics, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ophthalmic Biologics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ophthalmic Biologics total production and demand, 2019-2030, (K Units)
Global Ophthalmic Biologics total production value, 2019-2030, (USD Million)
Global Ophthalmic Biologics production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Ophthalmic Biologics consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Ophthalmic Biologics domestic production, consumption, key domestic manufacturers and share
Global Ophthalmic Biologics production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Ophthalmic Biologics production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Ophthalmic Biologics production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Ophthalmic Biologics market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio
, Regeneron and Qilu Pharmaceutical Co.,Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ophthalmic Biologics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Ophthalmic Biologics Market, By Region:
1. How big is the global Ophthalmic Biologics market?
2. What is the demand of the global Ophthalmic Biologics market?
3. What is the year over year growth of the global Ophthalmic Biologics market?
4. What is the production and production value of the global Ophthalmic Biologics market?
5. Who are the key producers in the global Ophthalmic Biologics market?
This report studies the global Ophthalmic Biologics production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Ophthalmic Biologics, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2023 as the base year. This report explores demand trends and competition, as well as details the characteristics of Ophthalmic Biologics that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Ophthalmic Biologics total production and demand, 2019-2030, (K Units)
Global Ophthalmic Biologics total production value, 2019-2030, (USD Million)
Global Ophthalmic Biologics production by region & country, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Ophthalmic Biologics consumption by region & country, CAGR, 2019-2030 & (K Units)
U.S. VS China: Ophthalmic Biologics domestic production, consumption, key domestic manufacturers and share
Global Ophthalmic Biologics production by manufacturer, production, price, value and market share 2019-2024, (USD Million) & (K Units)
Global Ophthalmic Biologics production by Type, production, value, CAGR, 2019-2030, (USD Million) & (K Units)
Global Ophthalmic Biologics production by Application production, value, CAGR, 2019-2030, (USD Million) & (K Units).
This reports profiles key players in the global Ophthalmic Biologics market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Novartis, Bayer, Genentech, Apellis Pharmaceuticals, Inc., Coherus BioSciences Inc., Iveric Bio
, Regeneron and Qilu Pharmaceutical Co.,Ltd., etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Ophthalmic Biologics market.
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2019-2030 by year with 2023 as the base year, 2024 as the estimate year, and 2025-2030 as the forecast year.
Global Ophthalmic Biologics Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Ranibizumab
- Bevacizumab
- Aflibercept
- Brolucizumab
- Faricimab
- Others
- Age-related Macular Degeneration Treatment
- Diabetic Retinopathy Treatment
- Inhibit Abnormal Angiogenesis
- Sanofi
- Novartis
- Bayer
- Genentech
- Apellis Pharmaceuticals, Inc.
- Coherus BioSciences Inc.
- Iveric Bio
- Regeneron
- Qilu Pharmaceutical Co.,Ltd.
- Chengdu Kanghong Pharmaceutical Group
1. How big is the global Ophthalmic Biologics market?
2. What is the demand of the global Ophthalmic Biologics market?
3. What is the year over year growth of the global Ophthalmic Biologics market?
4. What is the production and production value of the global Ophthalmic Biologics market?
5. Who are the key producers in the global Ophthalmic Biologics market?
1 SUPPLY SUMMARY
1.1 Ophthalmic Biologics Introduction
1.2 World Ophthalmic Biologics Supply & Forecast
1.2.1 World Ophthalmic Biologics Production Value (2019 & 2023 & 2030)
1.2.2 World Ophthalmic Biologics Production (2019-2030)
1.2.3 World Ophthalmic Biologics Pricing Trends (2019-2030)
1.3 World Ophthalmic Biologics Production by Region (Based on Production Site)
1.3.1 World Ophthalmic Biologics Production Value by Region (2019-2030)
1.3.2 World Ophthalmic Biologics Production by Region (2019-2030)
1.3.3 World Ophthalmic Biologics Average Price by Region (2019-2030)
1.3.4 North America Ophthalmic Biologics Production (2019-2030)
1.3.5 Europe Ophthalmic Biologics Production (2019-2030)
1.3.6 China Ophthalmic Biologics Production (2019-2030)
1.3.7 Japan Ophthalmic Biologics Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ophthalmic Biologics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ophthalmic Biologics Major Market Trends
2 DEMAND SUMMARY
2.1 World Ophthalmic Biologics Demand (2019-2030)
2.2 World Ophthalmic Biologics Consumption by Region
2.2.1 World Ophthalmic Biologics Consumption by Region (2019-2024)
2.2.2 World Ophthalmic Biologics Consumption Forecast by Region (2025-2030)
2.3 United States Ophthalmic Biologics Consumption (2019-2030)
2.4 China Ophthalmic Biologics Consumption (2019-2030)
2.5 Europe Ophthalmic Biologics Consumption (2019-2030)
2.6 Japan Ophthalmic Biologics Consumption (2019-2030)
2.7 South Korea Ophthalmic Biologics Consumption (2019-2030)
2.8 ASEAN Ophthalmic Biologics Consumption (2019-2030)
2.9 India Ophthalmic Biologics Consumption (2019-2030)
3 WORLD OPHTHALMIC BIOLOGICS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Ophthalmic Biologics Production Value by Manufacturer (2019-2024)
3.2 World Ophthalmic Biologics Production by Manufacturer (2019-2024)
3.3 World Ophthalmic Biologics Average Price by Manufacturer (2019-2024)
3.4 Ophthalmic Biologics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Ophthalmic Biologics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Ophthalmic Biologics in 2023
3.5.3 Global Concentration Ratios (CR8) for Ophthalmic Biologics in 2023
3.6 Ophthalmic Biologics Market: Overall Company Footprint Analysis
3.6.1 Ophthalmic Biologics Market: Region Footprint
3.6.2 Ophthalmic Biologics Market: Company Product Type Footprint
3.6.3 Ophthalmic Biologics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Ophthalmic Biologics Production Value Comparison
4.1.1 United States VS China: Ophthalmic Biologics Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Ophthalmic Biologics Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Ophthalmic Biologics Production Comparison
4.2.1 United States VS China: Ophthalmic Biologics Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Ophthalmic Biologics Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Ophthalmic Biologics Consumption Comparison
4.3.1 United States VS China: Ophthalmic Biologics Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Ophthalmic Biologics Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Ophthalmic Biologics Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Ophthalmic Biologics Production Value (2019-2024)
4.4.3 United States Based Manufacturers Ophthalmic Biologics Production (2019-2024)
4.5 China Based Ophthalmic Biologics Manufacturers and Market Share
4.5.1 China Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Ophthalmic Biologics Production Value (2019-2024)
4.5.3 China Based Manufacturers Ophthalmic Biologics Production (2019-2024)
4.6 Rest of World Based Ophthalmic Biologics Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Ophthalmic Biologics Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Ophthalmic Biologics Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Ophthalmic Biologics Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Ranibizumab
5.2.2 Bevacizumab
5.2.3 Aflibercept
5.2.4 Brolucizumab
5.2.5 Faricimab
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Ophthalmic Biologics Production by Type (2019-2030)
5.3.2 World Ophthalmic Biologics Production Value by Type (2019-2030)
5.3.3 World Ophthalmic Biologics Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Ophthalmic Biologics Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Age-related Macular Degeneration Treatment
6.2.2 Diabetic Retinopathy Treatment
6.2.3 Inhibit Abnormal Angiogenesis
6.3 Market Segment by Application
6.3.1 World Ophthalmic Biologics Production by Application (2019-2030)
6.3.2 World Ophthalmic Biologics Production Value by Application (2019-2030)
6.3.3 World Ophthalmic Biologics Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Ophthalmic Biologics Product and Services
7.1.4 Sanofi Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Ophthalmic Biologics Product and Services
7.2.4 Novartis Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Bayer
7.3.1 Bayer Details
7.3.2 Bayer Major Business
7.3.3 Bayer Ophthalmic Biologics Product and Services
7.3.4 Bayer Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bayer Recent Developments/Updates
7.3.6 Bayer Competitive Strengths & Weaknesses
7.4 Genentech
7.4.1 Genentech Details
7.4.2 Genentech Major Business
7.4.3 Genentech Ophthalmic Biologics Product and Services
7.4.4 Genentech Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Genentech Recent Developments/Updates
7.4.6 Genentech Competitive Strengths & Weaknesses
7.5 Apellis Pharmaceuticals, Inc.
7.5.1 Apellis Pharmaceuticals, Inc. Details
7.5.2 Apellis Pharmaceuticals, Inc. Major Business
7.5.3 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product and Services
7.5.4 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
7.5.6 Apellis Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.6 Coherus BioSciences Inc.
7.6.1 Coherus BioSciences Inc. Details
7.6.2 Coherus BioSciences Inc. Major Business
7.6.3 Coherus BioSciences Inc. Ophthalmic Biologics Product and Services
7.6.4 Coherus BioSciences Inc. Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Coherus BioSciences Inc. Recent Developments/Updates
7.6.6 Coherus BioSciences Inc. Competitive Strengths & Weaknesses
7.7 Iveric Bio
7.7.1 Iveric Bio
Details
7.7.2 Iveric Bio
Major Business
7.7.3 Iveric Bio
Ophthalmic Biologics Product and Services
7.7.4 Iveric Bio
Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Iveric Bio
Recent Developments/Updates
7.7.6 Iveric Bio
Competitive Strengths & Weaknesses
7.8 Regeneron
7.8.1 Regeneron Details
7.8.2 Regeneron Major Business
7.8.3 Regeneron Ophthalmic Biologics Product and Services
7.8.4 Regeneron Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Regeneron Recent Developments/Updates
7.8.6 Regeneron Competitive Strengths & Weaknesses
7.9 Qilu Pharmaceutical Co.,Ltd.
7.9.1 Qilu Pharmaceutical Co.,Ltd. Details
7.9.2 Qilu Pharmaceutical Co.,Ltd. Major Business
7.9.3 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product and Services
7.9.4 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.9.6 Qilu Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
7.10 Chengdu Kanghong Pharmaceutical Group
7.10.1 Chengdu Kanghong Pharmaceutical Group Details
7.10.2 Chengdu Kanghong Pharmaceutical Group Major Business
7.10.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product and Services
7.10.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
7.10.6 Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Ophthalmic Biologics Industry Chain
8.2 Ophthalmic Biologics Upstream Analysis
8.2.1 Ophthalmic Biologics Core Raw Materials
8.2.2 Main Manufacturers of Ophthalmic Biologics Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Ophthalmic Biologics Production Mode
8.6 Ophthalmic Biologics Procurement Model
8.7 Ophthalmic Biologics Industry Sales Model and Sales Channels
8.7.1 Ophthalmic Biologics Sales Model
8.7.2 Ophthalmic Biologics Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Ophthalmic Biologics Introduction
1.2 World Ophthalmic Biologics Supply & Forecast
1.2.1 World Ophthalmic Biologics Production Value (2019 & 2023 & 2030)
1.2.2 World Ophthalmic Biologics Production (2019-2030)
1.2.3 World Ophthalmic Biologics Pricing Trends (2019-2030)
1.3 World Ophthalmic Biologics Production by Region (Based on Production Site)
1.3.1 World Ophthalmic Biologics Production Value by Region (2019-2030)
1.3.2 World Ophthalmic Biologics Production by Region (2019-2030)
1.3.3 World Ophthalmic Biologics Average Price by Region (2019-2030)
1.3.4 North America Ophthalmic Biologics Production (2019-2030)
1.3.5 Europe Ophthalmic Biologics Production (2019-2030)
1.3.6 China Ophthalmic Biologics Production (2019-2030)
1.3.7 Japan Ophthalmic Biologics Production (2019-2030)
1.4 Market Drivers, Restraints and Trends
1.4.1 Ophthalmic Biologics Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Ophthalmic Biologics Major Market Trends
2 DEMAND SUMMARY
2.1 World Ophthalmic Biologics Demand (2019-2030)
2.2 World Ophthalmic Biologics Consumption by Region
2.2.1 World Ophthalmic Biologics Consumption by Region (2019-2024)
2.2.2 World Ophthalmic Biologics Consumption Forecast by Region (2025-2030)
2.3 United States Ophthalmic Biologics Consumption (2019-2030)
2.4 China Ophthalmic Biologics Consumption (2019-2030)
2.5 Europe Ophthalmic Biologics Consumption (2019-2030)
2.6 Japan Ophthalmic Biologics Consumption (2019-2030)
2.7 South Korea Ophthalmic Biologics Consumption (2019-2030)
2.8 ASEAN Ophthalmic Biologics Consumption (2019-2030)
2.9 India Ophthalmic Biologics Consumption (2019-2030)
3 WORLD OPHTHALMIC BIOLOGICS MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Ophthalmic Biologics Production Value by Manufacturer (2019-2024)
3.2 World Ophthalmic Biologics Production by Manufacturer (2019-2024)
3.3 World Ophthalmic Biologics Average Price by Manufacturer (2019-2024)
3.4 Ophthalmic Biologics Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Ophthalmic Biologics Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Ophthalmic Biologics in 2023
3.5.3 Global Concentration Ratios (CR8) for Ophthalmic Biologics in 2023
3.6 Ophthalmic Biologics Market: Overall Company Footprint Analysis
3.6.1 Ophthalmic Biologics Market: Region Footprint
3.6.2 Ophthalmic Biologics Market: Company Product Type Footprint
3.6.3 Ophthalmic Biologics Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Ophthalmic Biologics Production Value Comparison
4.1.1 United States VS China: Ophthalmic Biologics Production Value Comparison (2019 & 2023 & 2030)
4.1.2 United States VS China: Ophthalmic Biologics Production Value Market Share Comparison (2019 & 2023 & 2030)
4.2 United States VS China: Ophthalmic Biologics Production Comparison
4.2.1 United States VS China: Ophthalmic Biologics Production Comparison (2019 & 2023 & 2030)
4.2.2 United States VS China: Ophthalmic Biologics Production Market Share Comparison (2019 & 2023 & 2030)
4.3 United States VS China: Ophthalmic Biologics Consumption Comparison
4.3.1 United States VS China: Ophthalmic Biologics Consumption Comparison (2019 & 2023 & 2030)
4.3.2 United States VS China: Ophthalmic Biologics Consumption Market Share Comparison (2019 & 2023 & 2030)
4.4 United States Based Ophthalmic Biologics Manufacturers and Market Share, 2019-2024
4.4.1 United States Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Ophthalmic Biologics Production Value (2019-2024)
4.4.3 United States Based Manufacturers Ophthalmic Biologics Production (2019-2024)
4.5 China Based Ophthalmic Biologics Manufacturers and Market Share
4.5.1 China Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Ophthalmic Biologics Production Value (2019-2024)
4.5.3 China Based Manufacturers Ophthalmic Biologics Production (2019-2024)
4.6 Rest of World Based Ophthalmic Biologics Manufacturers and Market Share, 2019-2024
4.6.1 Rest of World Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Ophthalmic Biologics Production Value (2019-2024)
4.6.3 Rest of World Based Manufacturers Ophthalmic Biologics Production (2019-2024)
5 MARKET ANALYSIS BY TYPE
5.1 World Ophthalmic Biologics Market Size Overview by Type: 2019 VS 2023 VS 2030
5.2 Segment Introduction by Type
5.2.1 Ranibizumab
5.2.2 Bevacizumab
5.2.3 Aflibercept
5.2.4 Brolucizumab
5.2.5 Faricimab
5.2.6 Others
5.3 Market Segment by Type
5.3.1 World Ophthalmic Biologics Production by Type (2019-2030)
5.3.2 World Ophthalmic Biologics Production Value by Type (2019-2030)
5.3.3 World Ophthalmic Biologics Average Price by Type (2019-2030)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Ophthalmic Biologics Market Size Overview by Application: 2019 VS 2023 VS 2030
6.2 Segment Introduction by Application
6.2.1 Age-related Macular Degeneration Treatment
6.2.2 Diabetic Retinopathy Treatment
6.2.3 Inhibit Abnormal Angiogenesis
6.3 Market Segment by Application
6.3.1 World Ophthalmic Biologics Production by Application (2019-2030)
6.3.2 World Ophthalmic Biologics Production Value by Application (2019-2030)
6.3.3 World Ophthalmic Biologics Average Price by Application (2019-2030)
7 COMPANY PROFILES
7.1 Sanofi
7.1.1 Sanofi Details
7.1.2 Sanofi Major Business
7.1.3 Sanofi Ophthalmic Biologics Product and Services
7.1.4 Sanofi Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.1.5 Sanofi Recent Developments/Updates
7.1.6 Sanofi Competitive Strengths & Weaknesses
7.2 Novartis
7.2.1 Novartis Details
7.2.2 Novartis Major Business
7.2.3 Novartis Ophthalmic Biologics Product and Services
7.2.4 Novartis Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.2.5 Novartis Recent Developments/Updates
7.2.6 Novartis Competitive Strengths & Weaknesses
7.3 Bayer
7.3.1 Bayer Details
7.3.2 Bayer Major Business
7.3.3 Bayer Ophthalmic Biologics Product and Services
7.3.4 Bayer Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.3.5 Bayer Recent Developments/Updates
7.3.6 Bayer Competitive Strengths & Weaknesses
7.4 Genentech
7.4.1 Genentech Details
7.4.2 Genentech Major Business
7.4.3 Genentech Ophthalmic Biologics Product and Services
7.4.4 Genentech Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.4.5 Genentech Recent Developments/Updates
7.4.6 Genentech Competitive Strengths & Weaknesses
7.5 Apellis Pharmaceuticals, Inc.
7.5.1 Apellis Pharmaceuticals, Inc. Details
7.5.2 Apellis Pharmaceuticals, Inc. Major Business
7.5.3 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product and Services
7.5.4 Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.5.5 Apellis Pharmaceuticals, Inc. Recent Developments/Updates
7.5.6 Apellis Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
7.6 Coherus BioSciences Inc.
7.6.1 Coherus BioSciences Inc. Details
7.6.2 Coherus BioSciences Inc. Major Business
7.6.3 Coherus BioSciences Inc. Ophthalmic Biologics Product and Services
7.6.4 Coherus BioSciences Inc. Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.6.5 Coherus BioSciences Inc. Recent Developments/Updates
7.6.6 Coherus BioSciences Inc. Competitive Strengths & Weaknesses
7.7 Iveric Bio
7.7.1 Iveric Bio
Details
7.7.2 Iveric Bio
Major Business
7.7.3 Iveric Bio
Ophthalmic Biologics Product and Services
7.7.4 Iveric Bio
Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.7.5 Iveric Bio
Recent Developments/Updates
7.7.6 Iveric Bio
Competitive Strengths & Weaknesses
7.8 Regeneron
7.8.1 Regeneron Details
7.8.2 Regeneron Major Business
7.8.3 Regeneron Ophthalmic Biologics Product and Services
7.8.4 Regeneron Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.8.5 Regeneron Recent Developments/Updates
7.8.6 Regeneron Competitive Strengths & Weaknesses
7.9 Qilu Pharmaceutical Co.,Ltd.
7.9.1 Qilu Pharmaceutical Co.,Ltd. Details
7.9.2 Qilu Pharmaceutical Co.,Ltd. Major Business
7.9.3 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product and Services
7.9.4 Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.9.5 Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
7.9.6 Qilu Pharmaceutical Co.,Ltd. Competitive Strengths & Weaknesses
7.10 Chengdu Kanghong Pharmaceutical Group
7.10.1 Chengdu Kanghong Pharmaceutical Group Details
7.10.2 Chengdu Kanghong Pharmaceutical Group Major Business
7.10.3 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product and Services
7.10.4 Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Production, Price, Value, Gross Margin and Market Share (2019-2024)
7.10.5 Chengdu Kanghong Pharmaceutical Group Recent Developments/Updates
7.10.6 Chengdu Kanghong Pharmaceutical Group Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Ophthalmic Biologics Industry Chain
8.2 Ophthalmic Biologics Upstream Analysis
8.2.1 Ophthalmic Biologics Core Raw Materials
8.2.2 Main Manufacturers of Ophthalmic Biologics Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Ophthalmic Biologics Production Mode
8.6 Ophthalmic Biologics Procurement Model
8.7 Ophthalmic Biologics Industry Sales Model and Sales Channels
8.7.1 Ophthalmic Biologics Sales Model
8.7.2 Ophthalmic Biologics Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Ophthalmic Biologics Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Ophthalmic Biologics Production Value by Region (2019-2024) & (USD Million)
Table 3. World Ophthalmic Biologics Production Value by Region (2025-2030) & (USD Million)
Table 4. World Ophthalmic Biologics Production Value Market Share by Region (2019-2024)
Table 5. World Ophthalmic Biologics Production Value Market Share by Region (2025-2030)
Table 6. World Ophthalmic Biologics Production by Region (2019-2024) & (K Units)
Table 7. World Ophthalmic Biologics Production by Region (2025-2030) & (K Units)
Table 8. World Ophthalmic Biologics Production Market Share by Region (2019-2024)
Table 9. World Ophthalmic Biologics Production Market Share by Region (2025-2030)
Table 10. World Ophthalmic Biologics Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Ophthalmic Biologics Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Ophthalmic Biologics Major Market Trends
Table 13. World Ophthalmic Biologics Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Ophthalmic Biologics Consumption by Region (2019-2024) & (K Units)
Table 15. World Ophthalmic Biologics Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Ophthalmic Biologics Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Ophthalmic Biologics Producers in 2023
Table 18. World Ophthalmic Biologics Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Ophthalmic Biologics Producers in 2023
Table 20. World Ophthalmic Biologics Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Ophthalmic Biologics Company Evaluation Quadrant
Table 22. World Ophthalmic Biologics Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Ophthalmic Biologics Production Site of Key Manufacturer
Table 24. Ophthalmic Biologics Market: Company Product Type Footprint
Table 25. Ophthalmic Biologics Market: Company Product Application Footprint
Table 26. Ophthalmic Biologics Competitive Factors
Table 27. Ophthalmic Biologics New Entrant and Capacity Expansion Plans
Table 28. Ophthalmic Biologics Mergers & Acquisitions Activity
Table 29. United States VS China Ophthalmic Biologics Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Ophthalmic Biologics Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Ophthalmic Biologics Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ophthalmic Biologics Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Ophthalmic Biologics Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Ophthalmic Biologics Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Ophthalmic Biologics Production Market Share (2019-2024)
Table 37. China Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ophthalmic Biologics Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Ophthalmic Biologics Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Ophthalmic Biologics Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Ophthalmic Biologics Production Market Share (2019-2024)
Table 42. Rest of World Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Ophthalmic Biologics Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Ophthalmic Biologics Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Ophthalmic Biologics Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Ophthalmic Biologics Production Market Share (2019-2024)
Table 47. World Ophthalmic Biologics Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Ophthalmic Biologics Production by Type (2019-2024) & (K Units)
Table 49. World Ophthalmic Biologics Production by Type (2025-2030) & (K Units)
Table 50. World Ophthalmic Biologics Production Value by Type (2019-2024) & (USD Million)
Table 51. World Ophthalmic Biologics Production Value by Type (2025-2030) & (USD Million)
Table 52. World Ophthalmic Biologics Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Ophthalmic Biologics Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Ophthalmic Biologics Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Ophthalmic Biologics Production by Application (2019-2024) & (K Units)
Table 56. World Ophthalmic Biologics Production by Application (2025-2030) & (K Units)
Table 57. World Ophthalmic Biologics Production Value by Application (2019-2024) & (USD Million)
Table 58. World Ophthalmic Biologics Production Value by Application (2025-2030) & (USD Million)
Table 59. World Ophthalmic Biologics Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Ophthalmic Biologics Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Ophthalmic Biologics Product and Services
Table 64. Sanofi Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Major Business
Table 69. Novartis Ophthalmic Biologics Product and Services
Table 70. Novartis Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Novartis Recent Developments/Updates
Table 72. Novartis Competitive Strengths & Weaknesses
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Ophthalmic Biologics Product and Services
Table 76. Bayer Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Bayer Recent Developments/Updates
Table 78. Bayer Competitive Strengths & Weaknesses
Table 79. Genentech Basic Information, Manufacturing Base and Competitors
Table 80. Genentech Major Business
Table 81. Genentech Ophthalmic Biologics Product and Services
Table 82. Genentech Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Genentech Recent Developments/Updates
Table 84. Genentech Competitive Strengths & Weaknesses
Table 85. Apellis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Apellis Pharmaceuticals, Inc. Major Business
Table 87. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product and Services
Table 88. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 90. Apellis Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 91. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Coherus BioSciences Inc. Major Business
Table 93. Coherus BioSciences Inc. Ophthalmic Biologics Product and Services
Table 94. Coherus BioSciences Inc. Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Coherus BioSciences Inc. Recent Developments/Updates
Table 96. Coherus BioSciences Inc. Competitive Strengths & Weaknesses
Table 97. Iveric Bio
Basic Information, Manufacturing Base and Competitors
Table 98. Iveric Bio
Major Business
Table 99. Iveric Bio
Ophthalmic Biologics Product and Services
Table 100. Iveric Bio
Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Iveric Bio
Recent Developments/Updates
Table 102. Iveric Bio
Competitive Strengths & Weaknesses
Table 103. Regeneron Basic Information, Manufacturing Base and Competitors
Table 104. Regeneron Major Business
Table 105. Regeneron Ophthalmic Biologics Product and Services
Table 106. Regeneron Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Regeneron Recent Developments/Updates
Table 108. Regeneron Competitive Strengths & Weaknesses
Table 109. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 110. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 111. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product and Services
Table 112. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 114. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 115. Chengdu Kanghong Pharmaceutical Group Major Business
Table 116. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product and Services
Table 117. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 118. Global Key Players of Ophthalmic Biologics Upstream (Raw Materials)
Table 119. Ophthalmic Biologics Typical Customers
Table 120. Ophthalmic Biologics Typical Distributors
LIST OF FIGURE
Figure 1. Ophthalmic Biologics Picture
Figure 2. World Ophthalmic Biologics Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Ophthalmic Biologics Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Ophthalmic Biologics Production (2019-2030) & (K Units)
Figure 5. World Ophthalmic Biologics Average Price (2019-2030) & (US$/Unit)
Figure 6. World Ophthalmic Biologics Production Value Market Share by Region (2019-2030)
Figure 7. World Ophthalmic Biologics Production Market Share by Region (2019-2030)
Figure 8. North America Ophthalmic Biologics Production (2019-2030) & (K Units)
Figure 9. Europe Ophthalmic Biologics Production (2019-2030) & (K Units)
Figure 10. China Ophthalmic Biologics Production (2019-2030) & (K Units)
Figure 11. Japan Ophthalmic Biologics Production (2019-2030) & (K Units)
Figure 12. Ophthalmic Biologics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 15. World Ophthalmic Biologics Consumption Market Share by Region (2019-2030)
Figure 16. United States Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 17. China Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 18. Europe Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 19. Japan Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 20. South Korea Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 22. India Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Ophthalmic Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Ophthalmic Biologics Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Ophthalmic Biologics Markets in 2023
Figure 26. United States VS China: Ophthalmic Biologics Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Ophthalmic Biologics Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Ophthalmic Biologics Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Ophthalmic Biologics Production Market Share 2023
Figure 30. China Based Manufacturers Ophthalmic Biologics Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Ophthalmic Biologics Production Market Share 2023
Figure 32. World Ophthalmic Biologics Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Ophthalmic Biologics Production Value Market Share by Type in 2023
Figure 34. Ranibizumab
Figure 35. Bevacizumab
Figure 36. Aflibercept
Figure 37. Brolucizumab
Figure 38. Faricimab
Figure 39. Others
Figure 40. World Ophthalmic Biologics Production Market Share by Type (2019-2030)
Figure 41. World Ophthalmic Biologics Production Value Market Share by Type (2019-2030)
Figure 42. World Ophthalmic Biologics Average Price by Type (2019-2030) & (US$/Unit)
Figure 43. World Ophthalmic Biologics Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 44. World Ophthalmic Biologics Production Value Market Share by Application in 2023
Figure 45. Age-related Macular Degeneration Treatment
Figure 46. Diabetic Retinopathy Treatment
Figure 47. Inhibit Abnormal Angiogenesis
Figure 48. World Ophthalmic Biologics Production Market Share by Application (2019-2030)
Figure 49. World Ophthalmic Biologics Production Value Market Share by Application (2019-2030)
Figure 50. World Ophthalmic Biologics Average Price by Application (2019-2030) & (US$/Unit)
Figure 51. Ophthalmic Biologics Industry Chain
Figure 52. Ophthalmic Biologics Procurement Model
Figure 53. Ophthalmic Biologics Sales Model
Figure 54. Ophthalmic Biologics Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
Table 1. World Ophthalmic Biologics Production Value by Region (2019, 2023 and 2030) & (USD Million)
Table 2. World Ophthalmic Biologics Production Value by Region (2019-2024) & (USD Million)
Table 3. World Ophthalmic Biologics Production Value by Region (2025-2030) & (USD Million)
Table 4. World Ophthalmic Biologics Production Value Market Share by Region (2019-2024)
Table 5. World Ophthalmic Biologics Production Value Market Share by Region (2025-2030)
Table 6. World Ophthalmic Biologics Production by Region (2019-2024) & (K Units)
Table 7. World Ophthalmic Biologics Production by Region (2025-2030) & (K Units)
Table 8. World Ophthalmic Biologics Production Market Share by Region (2019-2024)
Table 9. World Ophthalmic Biologics Production Market Share by Region (2025-2030)
Table 10. World Ophthalmic Biologics Average Price by Region (2019-2024) & (US$/Unit)
Table 11. World Ophthalmic Biologics Average Price by Region (2025-2030) & (US$/Unit)
Table 12. Ophthalmic Biologics Major Market Trends
Table 13. World Ophthalmic Biologics Consumption Growth Rate Forecast by Region (2019 & 2023 & 2030) & (K Units)
Table 14. World Ophthalmic Biologics Consumption by Region (2019-2024) & (K Units)
Table 15. World Ophthalmic Biologics Consumption Forecast by Region (2025-2030) & (K Units)
Table 16. World Ophthalmic Biologics Production Value by Manufacturer (2019-2024) & (USD Million)
Table 17. Production Value Market Share of Key Ophthalmic Biologics Producers in 2023
Table 18. World Ophthalmic Biologics Production by Manufacturer (2019-2024) & (K Units)
Table 19. Production Market Share of Key Ophthalmic Biologics Producers in 2023
Table 20. World Ophthalmic Biologics Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 21. Global Ophthalmic Biologics Company Evaluation Quadrant
Table 22. World Ophthalmic Biologics Industry Rank of Major Manufacturers, Based on Production Value in 2023
Table 23. Head Office and Ophthalmic Biologics Production Site of Key Manufacturer
Table 24. Ophthalmic Biologics Market: Company Product Type Footprint
Table 25. Ophthalmic Biologics Market: Company Product Application Footprint
Table 26. Ophthalmic Biologics Competitive Factors
Table 27. Ophthalmic Biologics New Entrant and Capacity Expansion Plans
Table 28. Ophthalmic Biologics Mergers & Acquisitions Activity
Table 29. United States VS China Ophthalmic Biologics Production Value Comparison, (2019 & 2023 & 2030) & (USD Million)
Table 30. United States VS China Ophthalmic Biologics Production Comparison, (2019 & 2023 & 2030) & (K Units)
Table 31. United States VS China Ophthalmic Biologics Consumption Comparison, (2019 & 2023 & 2030) & (K Units)
Table 32. United States Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Ophthalmic Biologics Production Value, (2019-2024) & (USD Million)
Table 34. United States Based Manufacturers Ophthalmic Biologics Production Value Market Share (2019-2024)
Table 35. United States Based Manufacturers Ophthalmic Biologics Production (2019-2024) & (K Units)
Table 36. United States Based Manufacturers Ophthalmic Biologics Production Market Share (2019-2024)
Table 37. China Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Ophthalmic Biologics Production Value, (2019-2024) & (USD Million)
Table 39. China Based Manufacturers Ophthalmic Biologics Production Value Market Share (2019-2024)
Table 40. China Based Manufacturers Ophthalmic Biologics Production (2019-2024) & (K Units)
Table 41. China Based Manufacturers Ophthalmic Biologics Production Market Share (2019-2024)
Table 42. Rest of World Based Ophthalmic Biologics Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Ophthalmic Biologics Production Value, (2019-2024) & (USD Million)
Table 44. Rest of World Based Manufacturers Ophthalmic Biologics Production Value Market Share (2019-2024)
Table 45. Rest of World Based Manufacturers Ophthalmic Biologics Production (2019-2024) & (K Units)
Table 46. Rest of World Based Manufacturers Ophthalmic Biologics Production Market Share (2019-2024)
Table 47. World Ophthalmic Biologics Production Value by Type, (USD Million), 2019 & 2023 & 2030
Table 48. World Ophthalmic Biologics Production by Type (2019-2024) & (K Units)
Table 49. World Ophthalmic Biologics Production by Type (2025-2030) & (K Units)
Table 50. World Ophthalmic Biologics Production Value by Type (2019-2024) & (USD Million)
Table 51. World Ophthalmic Biologics Production Value by Type (2025-2030) & (USD Million)
Table 52. World Ophthalmic Biologics Average Price by Type (2019-2024) & (US$/Unit)
Table 53. World Ophthalmic Biologics Average Price by Type (2025-2030) & (US$/Unit)
Table 54. World Ophthalmic Biologics Production Value by Application, (USD Million), 2019 & 2023 & 2030
Table 55. World Ophthalmic Biologics Production by Application (2019-2024) & (K Units)
Table 56. World Ophthalmic Biologics Production by Application (2025-2030) & (K Units)
Table 57. World Ophthalmic Biologics Production Value by Application (2019-2024) & (USD Million)
Table 58. World Ophthalmic Biologics Production Value by Application (2025-2030) & (USD Million)
Table 59. World Ophthalmic Biologics Average Price by Application (2019-2024) & (US$/Unit)
Table 60. World Ophthalmic Biologics Average Price by Application (2025-2030) & (US$/Unit)
Table 61. Sanofi Basic Information, Manufacturing Base and Competitors
Table 62. Sanofi Major Business
Table 63. Sanofi Ophthalmic Biologics Product and Services
Table 64. Sanofi Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 65. Sanofi Recent Developments/Updates
Table 66. Sanofi Competitive Strengths & Weaknesses
Table 67. Novartis Basic Information, Manufacturing Base and Competitors
Table 68. Novartis Major Business
Table 69. Novartis Ophthalmic Biologics Product and Services
Table 70. Novartis Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 71. Novartis Recent Developments/Updates
Table 72. Novartis Competitive Strengths & Weaknesses
Table 73. Bayer Basic Information, Manufacturing Base and Competitors
Table 74. Bayer Major Business
Table 75. Bayer Ophthalmic Biologics Product and Services
Table 76. Bayer Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Bayer Recent Developments/Updates
Table 78. Bayer Competitive Strengths & Weaknesses
Table 79. Genentech Basic Information, Manufacturing Base and Competitors
Table 80. Genentech Major Business
Table 81. Genentech Ophthalmic Biologics Product and Services
Table 82. Genentech Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 83. Genentech Recent Developments/Updates
Table 84. Genentech Competitive Strengths & Weaknesses
Table 85. Apellis Pharmaceuticals, Inc. Basic Information, Manufacturing Base and Competitors
Table 86. Apellis Pharmaceuticals, Inc. Major Business
Table 87. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Product and Services
Table 88. Apellis Pharmaceuticals, Inc. Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Apellis Pharmaceuticals, Inc. Recent Developments/Updates
Table 90. Apellis Pharmaceuticals, Inc. Competitive Strengths & Weaknesses
Table 91. Coherus BioSciences Inc. Basic Information, Manufacturing Base and Competitors
Table 92. Coherus BioSciences Inc. Major Business
Table 93. Coherus BioSciences Inc. Ophthalmic Biologics Product and Services
Table 94. Coherus BioSciences Inc. Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 95. Coherus BioSciences Inc. Recent Developments/Updates
Table 96. Coherus BioSciences Inc. Competitive Strengths & Weaknesses
Table 97. Iveric Bio
Basic Information, Manufacturing Base and Competitors
Table 98. Iveric Bio
Major Business
Table 99. Iveric Bio
Ophthalmic Biologics Product and Services
Table 100. Iveric Bio
Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 101. Iveric Bio
Recent Developments/Updates
Table 102. Iveric Bio
Competitive Strengths & Weaknesses
Table 103. Regeneron Basic Information, Manufacturing Base and Competitors
Table 104. Regeneron Major Business
Table 105. Regeneron Ophthalmic Biologics Product and Services
Table 106. Regeneron Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 107. Regeneron Recent Developments/Updates
Table 108. Regeneron Competitive Strengths & Weaknesses
Table 109. Qilu Pharmaceutical Co.,Ltd. Basic Information, Manufacturing Base and Competitors
Table 110. Qilu Pharmaceutical Co.,Ltd. Major Business
Table 111. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Product and Services
Table 112. Qilu Pharmaceutical Co.,Ltd. Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 113. Qilu Pharmaceutical Co.,Ltd. Recent Developments/Updates
Table 114. Chengdu Kanghong Pharmaceutical Group Basic Information, Manufacturing Base and Competitors
Table 115. Chengdu Kanghong Pharmaceutical Group Major Business
Table 116. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Product and Services
Table 117. Chengdu Kanghong Pharmaceutical Group Ophthalmic Biologics Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2019-2024)
Table 118. Global Key Players of Ophthalmic Biologics Upstream (Raw Materials)
Table 119. Ophthalmic Biologics Typical Customers
Table 120. Ophthalmic Biologics Typical Distributors
LIST OF FIGURE
Figure 1. Ophthalmic Biologics Picture
Figure 2. World Ophthalmic Biologics Production Value: 2019 & 2023 & 2030, (USD Million)
Figure 3. World Ophthalmic Biologics Production Value and Forecast (2019-2030) & (USD Million)
Figure 4. World Ophthalmic Biologics Production (2019-2030) & (K Units)
Figure 5. World Ophthalmic Biologics Average Price (2019-2030) & (US$/Unit)
Figure 6. World Ophthalmic Biologics Production Value Market Share by Region (2019-2030)
Figure 7. World Ophthalmic Biologics Production Market Share by Region (2019-2030)
Figure 8. North America Ophthalmic Biologics Production (2019-2030) & (K Units)
Figure 9. Europe Ophthalmic Biologics Production (2019-2030) & (K Units)
Figure 10. China Ophthalmic Biologics Production (2019-2030) & (K Units)
Figure 11. Japan Ophthalmic Biologics Production (2019-2030) & (K Units)
Figure 12. Ophthalmic Biologics Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 15. World Ophthalmic Biologics Consumption Market Share by Region (2019-2030)
Figure 16. United States Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 17. China Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 18. Europe Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 19. Japan Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 20. South Korea Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 21. ASEAN Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 22. India Ophthalmic Biologics Consumption (2019-2030) & (K Units)
Figure 23. Producer Shipments of Ophthalmic Biologics by Manufacturer Revenue ($MM) and Market Share (%): 2023
Figure 24. Global Four-firm Concentration Ratios (CR4) for Ophthalmic Biologics Markets in 2023
Figure 25. Global Four-firm Concentration Ratios (CR8) for Ophthalmic Biologics Markets in 2023
Figure 26. United States VS China: Ophthalmic Biologics Production Value Market Share Comparison (2019 & 2023 & 2030)
Figure 27. United States VS China: Ophthalmic Biologics Production Market Share Comparison (2019 & 2023 & 2030)
Figure 28. United States VS China: Ophthalmic Biologics Consumption Market Share Comparison (2019 & 2023 & 2030)
Figure 29. United States Based Manufacturers Ophthalmic Biologics Production Market Share 2023
Figure 30. China Based Manufacturers Ophthalmic Biologics Production Market Share 2023
Figure 31. Rest of World Based Manufacturers Ophthalmic Biologics Production Market Share 2023
Figure 32. World Ophthalmic Biologics Production Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 33. World Ophthalmic Biologics Production Value Market Share by Type in 2023
Figure 34. Ranibizumab
Figure 35. Bevacizumab
Figure 36. Aflibercept
Figure 37. Brolucizumab
Figure 38. Faricimab
Figure 39. Others
Figure 40. World Ophthalmic Biologics Production Market Share by Type (2019-2030)
Figure 41. World Ophthalmic Biologics Production Value Market Share by Type (2019-2030)
Figure 42. World Ophthalmic Biologics Average Price by Type (2019-2030) & (US$/Unit)
Figure 43. World Ophthalmic Biologics Production Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 44. World Ophthalmic Biologics Production Value Market Share by Application in 2023
Figure 45. Age-related Macular Degeneration Treatment
Figure 46. Diabetic Retinopathy Treatment
Figure 47. Inhibit Abnormal Angiogenesis
Figure 48. World Ophthalmic Biologics Production Market Share by Application (2019-2030)
Figure 49. World Ophthalmic Biologics Production Value Market Share by Application (2019-2030)
Figure 50. World Ophthalmic Biologics Average Price by Application (2019-2030) & (US$/Unit)
Figure 51. Ophthalmic Biologics Industry Chain
Figure 52. Ophthalmic Biologics Procurement Model
Figure 53. Ophthalmic Biologics Sales Model
Figure 54. Ophthalmic Biologics Sales Channels, Direct Sales, and Distribution
Figure 55. Methodology
Figure 56. Research Process and Data Source
